PIMJS

PKO Investment Management Joint-Stock Portfolio holdings

AUM $1.19B
1-Year Est. Return 38.3%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+38.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.19B
AUM Growth
-$65M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
234
New
Increased
Reduced
Closed

Top Buys

1
+$15.1M
2
+$5.56M
3
+$5.09M
4
B
Barrick Mining
B
+$4.77M
5
CDE icon
Coeur Mining
CDE
+$3.63M

Top Sells

1
+$10.5M
2
+$9.17M
3
+$6.83M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$5.98M
5
MSFT icon
Microsoft
MSFT
+$5.44M

Sector Composition

1 Technology 25.4%
2 Materials 21.77%
3 Consumer Discretionary 8.55%
4 Healthcare 8.25%
5 Communication Services 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGM icon
201
MGM Resorts International
MGM
$10.4B
$315K 0.03%
8,500
-1,500
SIG icon
202
Signet Jewelers
SIG
$3.52B
$296K 0.02%
3,500
LH icon
203
Labcorp
LH
$21.7B
$267K 0.02%
1,000
BIIB icon
204
Biogen
BIIB
$26.5B
$238K 0.02%
1,300
-700
ZBH icon
205
Zimmer Biomet
ZBH
$17.9B
$226K 0.02%
2,500
-1,200
SUNB
206
Sunbelt Rentals Holdings
SUNB
$30.8B
$218K 0.02%
+3,468
COO icon
207
Cooper Companies
COO
$12.6B
$215K 0.02%
3,000
PODD icon
208
Insulet
PODD
$13B
$210K 0.02%
1,000
+200
WST icon
209
West Pharmaceutical
WST
$21.3B
$201K 0.02%
800
INCY icon
210
Incyte
INCY
$19B
$198K 0.02%
2,100
DGX icon
211
Quest Diagnostics
DGX
$21.8B
$196K 0.02%
1,000
-500
ILMN icon
212
Illumina
ILMN
$19.5B
$185K 0.02%
1,500
NBIX icon
213
Neurocrine Biosciences
NBIX
$12.9B
$184K 0.02%
1,400
+100
UTHR icon
214
United Therapeutics
UTHR
$24.8B
$178K 0.02%
300
-200
CNC icon
215
Centene
CNC
$21.4B
$164K 0.01%
+5,000
RVMD icon
216
Revolution Medicines
RVMD
$27.8B
$146K 0.01%
+1,500
UHS icon
217
Universal Health Services
UHS
$11B
$143K 0.01%
800
+100
CPRI icon
218
Capri Holdings
CPRI
$2.43B
$132K 0.01%
7,500
RH icon
219
RH
RH
$2.56B
$115K 0.01%
824
-676
SOLV icon
220
Solventum
SOLV
$12.1B
$98K 0.01%
+1,500
AEP icon
221
American Electric Power
AEP
$73.4B
– –
-11,000
BAX icon
222
Baxter International
BAX
$9.55B
– –
-4,000
BMRN icon
223
BioMarin Pharmaceuticals
BMRN
$10.4B
– –
-4,500
CL icon
224
Colgate-Palmolive
CL
$67.5B
– –
-22,740
CRM icon
225
Salesforce
CRM
$147B
– –
-7,000
6 7 8
9
10